Xvivo Perfusion AB
XVIVO.ST
#5010
Rank
$1.34 B
Marketcap
$42.70
Share price
1.39%
Change (1 day)
34.07%
Change (1 year)
Categories

P/E ratio for Xvivo Perfusion AB (XVIVO.ST)

P/E ratio as of December 2024 (TTM): 300

According to Xvivo Perfusion AB's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 300.091. At the end of 2023 the company had a P/E ratio of 107.

P/E ratio history for Xvivo Perfusion AB from 2013 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023107-63.64%
2022295-70.32%
2021995-609.99%
2020-195-121.8%
2019895225.36%
2018275-26.86%
2017376-70.09%
2016> 1000415.75%
201524477.66%
201413767.92%
201381.7-116.1%
2012-507

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.